Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1998
05/19/1998US5753667 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application
05/19/1998US5753650 Inhibitors of farnesyl-protein transferase
05/19/1998US5753631 Intercellular adhesion mediators
05/19/1998US5753630 Method for treating and inhibiting gastric and duodenal ulcers
05/19/1998US5753628 Peptide inhibitors of TNF containing predominantly D-amino acids
05/19/1998US5753627 Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
05/19/1998US5753625 Administering polypeptide
05/19/1998US5753624 Materials and methods for treatment of plaquing disease
05/19/1998US5753623 Administering relaxin
05/19/1998US5753622 Use of epidermal growth factor as a gastrointestinal therapeutic agent
05/19/1998US5753621 Pulmonary surfactant protein fragments
05/19/1998US5753620 Antagonist to tumor necrosis factor and interleukins
05/19/1998US5753619 Composition for prophylaxis or treatment of pulmonary circulatory diseases
05/19/1998US5753618 Somatostatin analogue composition and use in treating breast cancer
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/19/1998US5753616 Method for producing a stable polymerized hemoglobin blood-substitute
05/19/1998US5753614 Nisin compositions for use as enhanced, broad range bactericides
05/19/1998US5753612 Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
05/19/1998US5753504 Using antibodies for inhibiting lipopolysaccharide binding protein mediated lipopolysaccharide-dependent secretion of tumor necrosis factor from myeloid cells
05/19/1998US5753491 Use of neuro-derived fetal cell lines for transplantation therapy
05/19/1998US5753487 Stabilised phenylalanine ammonia lyase
05/19/1998US5753486 Human tissue plasminogen activator
05/19/1998US5753480 Cysteinyl tRNA synthetase polynucleotides of streptococcus
05/19/1998US5753479 Genetic enginnering
05/19/1998US5753476 Identification of a human cytomegalovirus gene region involved in down regulation of MHC class I heavy chain expression
05/19/1998US5753465 Unmodified recombinant human adult hemoglobin production
05/19/1998US5753464 DNA encoding a polypeptide having pre-B cell growth-supporting ability
05/19/1998US5753459 Nucleic acid encoding treponema pallidum rare outer membrane protein useful in diagnosis and prophylaxis of syphilis
05/19/1998US5753446 Mitogen ERK kinase kinase (MEKK) assay
05/19/1998US5753441 Genetic engineering
05/19/1998US5753432 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
05/19/1998US5753268 Anti-cholesterolemic egg, vaccine and method for production, and use
05/19/1998US5753263 Method to deliver compositions conferring resistance to alopecia to hair follicles
05/19/1998US5753260 Vaccines against sterols
05/19/1998US5753247 Method of treating fungal infections
05/19/1998US5753231 Primate intra-acrosomal sperm antigen for use in a contraceptive vaccine
05/19/1998US5753230 Methods and compositions useful for inhibition of angiogenesis
05/19/1998US5753229 Detecting breast cancer
05/19/1998US5753228 Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
05/19/1998US5753226 Contacting cells with compound which binds to reovirus type 3 receptor
05/19/1998US5753225 Antibodies that mimic actions of neurotrophins
05/19/1998US5753219 Trehalose, controlled release
05/19/1998US5753218 Administering interleukin-10 and steroid
05/19/1998US5753206 Radiometal-binding analogues of luteinizing hormone releasing hormone
05/19/1998US5753203 CD30 ligand conjugates
05/19/1998US5753123 Method for purifying thrombomodulin
05/19/1998US5752974 Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
05/19/1998CA2190679A1 Lymphocyte tachykinin
05/19/1998CA2007507C Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
05/19/1998CA1339875C Modified human psti
05/19/1998CA1339873C Recombinant colony stimulating factor-1
05/15/1998CA2221391A1 Neuron and neural tumour growth regulatory system, antibodies thereto and uses thereof
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2190418A1 Neuron and neural tumor growth regulatory system, antibodies thereto and uses thereof
05/14/1998WO1998020169A1 Determination and control of bimolecular interactions
05/14/1998WO1998020168A1 Antisense oligonucleotides
05/14/1998WO1998020142A1 Notch
05/14/1998WO1998020141A1 Secretory immunoglobulin a as a mucosal vaccine delivery system
05/14/1998WO1998020140A1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof
05/14/1998WO1998020137A1 Human squalene epoxidase
05/14/1998WO1998020135A2 Protease-activatable pseudomonas exotoxin a-like proproteins
05/14/1998WO1998020132A1 Tumor-associated kazal inhibitor with pec-60 homology
05/14/1998WO1998020131A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
05/14/1998WO1998020130A2 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998020129A1 A human gene/protein involved in chronic myelogenous leukemia
05/14/1998WO1998020128A1 Human regulator of g-protein signaling - (hrgs)
05/14/1998WO1998020127A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/14/1998WO1998020126A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/14/1998WO1998020124A2 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998WO1998020119A1 Fatty-acid amide hydrolase
05/14/1998WO1998020118A1 Modified protein c and methods of use thereof
05/14/1998WO1998020117A1 Prostate-specific kallikrein
05/14/1998WO1998020110A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
05/14/1998WO1998020041A1 Endothelium specific expression regulated by epcr control elements
05/14/1998WO1998020040A1 Novel histamine h2 receptor
05/14/1998WO1998020037A1 Method for treating certain pediatric acute leukemias
05/14/1998WO1998020036A1 Constrained helical peptides and methods of making same
05/14/1998WO1998020034A2 Novel serine protease inhibitor nucleic acid molecules, proteins and uses thereof
05/14/1998WO1998020032A1 Sprouty protein and coding sequence
05/14/1998WO1998020030A2 DISRUPTION OF THE MAMMALIAN Rad51 PROTEIN AND DISRUPTION OF PROTEINS THAT ASSOCIATE WITH MAMMALIAN Rad51 FOR HINDERING CELL PROLIFERATION
05/14/1998WO1998020029A2 Hnf3-delta compositions
05/14/1998WO1998020028A2 Clavanins
05/14/1998WO1998020027A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
05/14/1998WO1998020026A1 Contryphan peptides
05/14/1998WO1998020023A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998WO1998020022A1 Soluble proteins
05/14/1998WO1998020021A1 Nucleotide and amino acid sequences of c4-2, a tumor suppressor gene, and methods of use thereof
05/14/1998WO1998020016A1 Novel coding sequences from herpes simplex virus type-2
05/14/1998WO1998019712A1 Methods for regulating angiogenesis
05/14/1998WO1998019706A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998WO1998019705A1 Branched peptide linkers
05/14/1998WO1998019704A1 Human monoclonal antibodies
05/14/1998WO1998019701A1 Methods for promoting wound healing and treating transplant-associated vasculopathy
05/14/1998WO1998019700A1 Treatment of inner ear hair cells
05/14/1998WO1998019699A1 Use of growth hormone or a growth hormone secretagogue for promoting bone formation
05/14/1998WO1998019698A1 Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity
05/14/1998WO1998019697A2 Novel pharmaceutical compositions
05/14/1998WO1998019696A1 Hepatocyte growth factor antagonists
05/14/1998WO1998019695A1 Device and method for delivery of erythropoietin
1 ... 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 ... 3163